EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type 2 Diabetes Mellitus Impairs the Reverse Transendothelial Migration Capacity (rTEM) of Inflammatory CD14+CD16− Monocytes: Novel Mechanism for Enhanced Subendothelial Monocyte Accumulation in Diabetes

Dilvin Semo iD, Adama Sidibé, Kallipatti Sanjith Shanmuganathan, Nicolle Müller iD, Ulrich A Müller, Beat A Imhof iD, Rinesh Godfrey, Johannes Waltenberger

Cells · 09.10.2025 · 14 (19) · 1567

DOI: 10.3390/cells14191567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 09.10.2025. Verfasst von Dilvin Semo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Signalling, Molecular Cardiology, Department of Cardiology I-Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Mü…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Monocytes, Transendothelial and Transepithelial Migration, Lipopolysaccharide Receptors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medizinische Forschung, Deutsche Forschungsgemeinschaft (DFG), Collaborative Research Centre 656, IZKF SEED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (DM) is a major cardiovascular risk factor that induces monocyte dysfunction and contributes to their accumulation in atherosclerotic lesions. Monocyte recruitment and accumulation in the tissues contribute to chronic inflammation and are essential to the pathobiology of diabetes-induced atherosclerosis. However, the mechanisms that drive the accumulation of monocytes in the diabetic environment are not clearly understood.

Methods

Primary monocytes from type 2 (T2) DM and non-T2DM individuals were isolated using magnet-assisted cell sorting. To examine the influence of a diabetic milieu on monocyte function, monocytes from T2DM patients, db/db mice, or human monocytes subjected to hyperglycaemia were analysed for their responses to pro-atherogenic cytokines using Boyden chamber assays. Furthermore, the interactions of non-diabetic and diabetic monocytes with TNFα-inflamed endothelium were studied using live-cell imaging under physiological flow conditions. RT-qPCR and FACS were used to study the expression of relevant molecules involved in monocyte-endothelium interaction.

Results

CD14+CD16− monocytes isolated from T2DM patients or monocytes exposed to hyperglycaemic conditions showed reduced chemotactic responses towards atherosclerosis-promoting cytokines, CCL2 and CX3CL1, indicating monocyte dysfunction. Under flow conditions, the transendothelial migration (TEM) capacity of T2DM monocytes was significantly reduced. Even though these monocytes adhered to the endothelial monolayer, only a few transmigrated. Interestingly, the T2DM monocytes and monocytes exposed to hyperglycaemic conditions accumulated in the ablumen following transendothelial migration. The time period in the ablumen of T2DM cells was prolonged, as there was a significant impairment of the reverse transendothelial migration (rTEM). Mechanistically, the T2DM milieu specifically induced the activation of monocyte integrins, Macrophage-1 antigen (Mac-1; integrin αMβ2 consisting of CD11b and CD18), and Lymphocyte function-associated antigen 1 (LFA-1; αLβ2 consisting of CD11a and CD18). Furthermore, elevated levels of CD18 transcripts were detected in T2DM monocytes. Junctional Adhesion Molecule 3 (JAM-3)–MAC-1 interactions are known to impede rTEM and T2DM milieu-potentiated JAM-3 expression in human coronary artery endothelial cells (HCAEC). Finally, the overexpression of JAM-3 on HCAEC was sufficient to completely recapitulate the impaired rTEM phenotype.

Conclusions

Our results revealed for the first time that the enhanced T2DM monocyte accumulation in the ablumen is not secondary to the elevated transmigration through the endothelium. Instead, the accumulation of monocytes is due to the direct consequence of a dysfunctional rTEM, potentially due to enhanced JAM3-MAC1 engagement. Our results highlight the importance of restoring the rTEM capacity of monocytes to reduce monocyte accumulation-dependent inflammation induction and atherogenesis in the T2DM environment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2MonocytesTransendothelial and Transepithelial MigrationLipopolysaccharide ReceptorsReceptors, IgGInflammationHumansAnimalsMaleMiceMiddle AgedFemaleAtherosclerosis

Stichwörter der Autor:innen

Junctional Adhesion Molecule 3 (JAM-3)Macrophage-1 antigen (MAC-1)adhesiondiabetes mellitusmonocytesreverse transendothelial migration (rTEM)vascular dysfunction

Substanzen

Lipopolysaccharide ReceptorsReceptors, IgG

Autor:innen und Institutionen

  • Vascular Signalling, Molecular Cardiology, Department of Cardiology I-Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Münster, 48149 Münster, Germany.
  • Department of Pathology and Immunology, Centre Médical Universitaire (CMU), Medical Faculty, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.
  • Department of Internal Medicine III, University Hospital Jena, 07743 Jena, Germany.
  • Practice for Endocrinology and Diabetes, MVZ Dr. Kielstein GmbH Erfurt, 07743 Jena, Germany.
  • Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), 6229 ER Maastricht, The Netherlands.
  • Department of Cardiovascular Medicine, Medical Faculty, University of Münster, 48149 Münster, Germany.

ORCID-Profile: Dilvin Semo, Nicolle Müller, Beat A Imhof

Förderung

  • Innovative Medizinische Forschung
  • Deutsche Forschungsgemeinschaft (DFG), Collaborative Research Centre 656
  • IZKF SEED
  • Deutsche Forschungsgemeinschaft (DFG), Collaborative Research Centre 656 Münster
  • Deanery of the Medical Faculty of the Westfälische Wilhelms-Universität Münster

Zitieren

APA

Semo, D., Sidibé, A., Shanmuganathan, K. S., Müller, N., Müller, U. A., Imhof, B. A., Godfrey, R., & Waltenberger, J. (2025). Type 2 Diabetes Mellitus Impairs the Reverse Transendothelial Migration Capacity (rTEM) of Inflammatory CD14+CD16− Monocytes: Novel Mechanism for Enhanced Subendothelial Monocyte Accumulation in Diabetes. Cells, 14(19), 1567. https://doi.org/10.3390/cells14191567

Vancouver

Semo D, Sidibé A, Shanmuganathan KS, Müller N, Müller UA, Imhof BA, et al. Type 2 Diabetes Mellitus Impairs the Reverse Transendothelial Migration Capacity (rTEM) of Inflammatory CD14+CD16− Monocytes: Novel Mechanism for Enhanced Subendothelial Monocyte Accumulation in Diabetes. Cells. 2025;14(19):1567. doi:10.3390/cells14191567

BibTeX
@article{Semo2025,
  author = {Semo, Dilvin and Sidibé, Adama and Shanmuganathan, Kallipatti Sanjith and Müller, Nicolle and Müller, Ulrich A and Imhof, Beat A and Godfrey, Rinesh and Waltenberger, Johannes},
  title = {Type 2 Diabetes Mellitus Impairs the Reverse Transendothelial Migration Capacity (rTEM) of Inflammatory CD14+CD16− Monocytes: Novel Mechanism for Enhanced Subendothelial Monocyte Accumulation in Diabetes},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {19},
  pages = {1567},
  doi = {10.3390/cells14191567}
}
Kostenlos starten →